Preoperative Low-Density Lipoprotein Apheresis for Preventing Recurrence of Focal Segmental Glomerulosclerosis after Kidney Transplantation

Table 1

Clinical characteristics of the patients.

	Case 1	Case 2	Case 3	Case 4	Case 5
Age at kidney transplantation (years)	41	24	38	33	27
Age at onset of FSGS (years)	40	11	32	26	17
Gender (male/female)	Female	Male	Female	Male	Female
Donor relationship	Mother	Mother	Mother	Mother	Mother
Dialysis duration (months)	2	29	0	0	0
Preoperative anti-HLA donor antibody	Negative	Negative	Negative	Negative	Negative
Preoperative dose of rituximab (mg)	100	100	100	100	100
Preoperative PE sessions (number)	2	0	0	0	0
Preoperative LDL apheresis sessions (number)	1	2	2	2	2
Postoperative observation period (months)	22	19	14	3	2

FSGS, focal segmental glomerulosclerosis; HLA, human leukocyte antigen; PE, plasma exchange; LDL, low-density lipoprotein.